Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 8/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 7/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9700600 | 0.89 | AGTR1 (0.34) | AGTR1AGTR2PPARG | |
| SCHEMBL9527172 | 0.88 | AGTR1 (0.34) | AGTR1AGTR2 | |
| SCHEMBL9529547 | 0.87 | AGTR1 (0.40) | AGTR1AGTR2PPARG | |
| SCHEMBL9527159 | 0.86 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL9531576 | 0.86 | AGTR1 (0.34) | AGTR1AGTR2 | |
| SCHEMBL9528631 | 0.86 | AGTR1 (0.38) | AGTR1AGTR2 | |
| SCHEMBL9528577 | 0.85 | AGTR1 (0.37) | AGTR1AGTR2 | |
| SCHEMBL9527701 | 0.85 | AGTR1 (0.36) | AGTR1AGTR2PPARGUSP1 | |
| SCHEMBL9530527 | 0.84 | AGTR1 (0.39) | AGTR1AGTR2PPARGUSP1 | |
| SCHEMBL6005989 | 0.84 | LTB4R2 (0.42) | AGTR1AGTR2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| US-5098920-A | Hypotensive agents and treatment of congestive heart failure | G. D. SEARLE & CO. (US) | 1992-03-24 | — | — | US | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |